SUBSCRIPTION
AGREEMENT

    

      
        	
                TO:

              	
                SYNTHEMED,
      INC.

              


      

       

      
        	
                AND
      TO:

              	
                CLUBB
      CAPITAL LIMITED

              


      

       

      
        	
                RE:

              	
                SUBSCRIPTION
      FOR UNITS

              


      

    

     

    1.           Subscription

     

    The
undersigned (the “Purchaser”) hereby irrevocably subscribes for on and subject
to the terms and conditions set forth herein, from SyntheMed, Inc., a Delaware
corporation (the “Corporation”), the number of units (the “Units”), set forth on
the signature page hereof (the “Purchased Units”).  Each Unit shall
consist of (i) one common share, $0.001(US) par value per share, in the capital
stock of the Corporation (a “Common Stock”) and (ii) one common share purchase
warrant (a “Warrant”).  Each Warrant, a sample copy of which is
appended as Annex A, will entitle the holder to purchase one Common Stock up and
until 5:00 p.m. (Eastern Standard Time) on September 30, 2013 upon payment of
the applicable exercise price of $0.20 (US), subject to adjustment as provided
in the Warrant certificate.

     

     The
Purchased Units are being sold to the Purchaser in consideration for $0.20 (US)
per Unit (the “Subscription Price”), and as part of an offering (the “Offering”)
of up to 10,000,000 Units.  If the maximum number of Units offered is
sold, the Corporation will receive gross proceeds of $2,000,000
(US).

     

    There is
no minimum number of Units being offered, and the Corporation reserves the right
to accept or reject subscriptions, in whole or in part, as and when received.
Clubb Capital Limited (the “Agent”) is serving as a placement agent for the
Offering pursuant to an agency agreement to be entered into with the Corporation
(the “Agency Agreement”).

     

    The
Offering is being made to investors resident outside the United States pursuant
to exemptions from local registration, prospectus or similar
requirements.  The Offering is being made in reliance upon the
exemption from registration under the Securities Act of 1933, as amended (the
“Securities Act”), provided by Section 4(2) thereof and/or Regulation D
promulgated thereunder and/or in reliance upon Regulation S promulgated under
the Securities Act and exemptions from local registration, prospectus or similar
requirements.

     

    2.           Use of
Proceeds

     

    The
proceeds of the Offering will be used by the Corporation to fund working capital
and general corporate purposes.


    
      
         


      

      
         


        
          

        

      

      
         


      

    

     

    3.           Documents and Payment to be
provided by the Purchaser

     

    The
Purchaser must complete, sign and return two executed copies of this
Subscription Agreement and the aggregate Subscription Price must be paid in U.S.
dollars by wire transfer to the following account:

     

    Bank of
America NT & SA

    100 West
33rd
Street

    New York,
NY 10048-1191

    Swiftcode:
BOFAUS3N

    ABA No.
026009593

    


    For
Further Credit to:

    Canadian
Imperial Bank of Commerce

    Main
Branch, Commerce Court West

    Toronto,
Ontario M5L 1A2

    Swiftcode:
CIBCCATT

    Transit
No. 00002

    Final
Beneficiary: Blake Cassels & Graydon LLP

    Account
No. 000020244414

    Reference:
JACK – 65418/58

    


    or in
such other manner as may be specified by the Agent.  At each Closing
(as defined below), the aggregate Subscription Price for all Purchased Units
subject to such Closing will be released to the Corporation by Blake, Cassels
& Graydon LLP on instructions from the Agent.  The deliveries
required pursuant to this Section 3 are hereinafter referred to as the
“Purchaser’s Closing Deliveries.”

     

    4.           Closing and Delivery of
Share Certificates

     

    Delivery
and sale of the Purchased Units will be completed (the “Closing”) at the offices
of the Corporation (or such other place or places as the Corporation and the
Agent may agree) at 10:00 a.m. (Eastern Standard Time) (the “Closing Time”)
on such date or dates as the Corporation and the Agent may agree (each a
“Closing Date”). The Final Closing (as defined below) is expected to occur on or
before October 30, 2009. As used herein, “Final Closing” means the date on which
the full amount of the Offering is sold or the earlier termination of the
Offering period as determined by the Corporation.

     

    Certificates
representing the Purchased Units (and/or the underlying securities) will be
delivered at Closing, or shortly thereafter, against delivery by the Purchaser
of the requisite funds by wire transfer.  The Purchaser, on its own
behalf or on behalf of others for whom it is contracting hereunder, agrees and
acknowledges that counsel for the Agent shall not be liable for any error in
judgment or for any act done or step taken or omitted by it in good faith or for
any mistake, in fact or law, or for anything which it may do or refrain from
doing with the performance of any obligations in this Section 4, except arising
out of its gross negligence or willful misconduct. The Purchaser, on its own
behalf or on behalf of others for whom it is contracting hereunder, hereby
appoints the Agent, with full power of substitution, as its true and lawful
attorney and agent with the full power and authority in its place and stead to
swear, execute, file and record any document necessary to give effect to the
delivery and sale of the Purchased Units, to terminate this subscription on its
behalf in the event that any condition precedent to the Offering has not been
satisfied, to execute a receipt for the Purchased Units and all other
documentation, and to modify or waive any conditions or grant any waivers on its
behalf in connection with this Subscription Agreement and the transactions
contemplated hereby.


    
      
         


      

      
        2

        
          

        

      

      
         


      

    

     

    5.           Certain Matters Relating to
the Offering

     

    The
Purchaser, on its own behalf (or on behalf of others for whom it is contracting
hereunder) acknowledges and agrees that:

     

    
      	
              (a)

            	
              this
      Subscription Agreement sets out the terms of the Purchaser’s
      subscription;

            


    

     

    
      	
              (b)

            	
              it
      (or others for whom it is contracting hereunder) has not been provided
      with, and has not requested, a prospectus or an offering memorandum or any
      similar document in connection with its purchase of
  Units;

            


    

     

    
      	
              (c)

            	
              no
      prospectus or offering memorandum has been filed by the Corporation with
      any securities commission or similar regulatory authority in any
      jurisdiction in connection with the issuance of any Units and, as a
      result;

            


    

     

    
      	
               
      

            	
              (i)

            	
              the
      Purchaser is restricted from using certain of the remedies available under
      applicable securities laws;

            


    

     

    
      	
               
      

            	
              (ii)

            	
              the
      Purchaser will not receive information that would otherwise be required to
      be provided to it under applicable securities laws;
  and

            


    

     

    
      	
               
      

            	
              (iii)

            	
              the
      Corporation is relieved from certain obligations that would otherwise
      apply under applicable securities
laws;

            


    

     

    
      	
              (d)

            	
              the
      sale and delivery of the Purchased Units was not accompanied by any
      advertisement of the Units, including, without limitation, in printed
      public media, radio, television or telecommunications, including
      electronic display or as part of a general
  solicitation;

            


    

     

    
      	
              (e)

            	
              no
      agency, governmental authority, securities commission or other regulatory
      body, stock exchange or other entity has made any finding or determination
      as to, or passed upon the merit for investment of, nor have any such
      agencies, governmental authorities, securities commissions or other
      regulatory bodies, stock exchanges or other entities made any
      recommendation or endorsement with respect to, the
  Units;

            


    

     

    
      	
              (f)

            	
              its
      decision to execute this Subscription Agreement and to subscribe for the
      Purchased Units (on its own behalf or on behalf of others for whom it is
      contracting hereunder) has not been based upon any verbal or written
      representations as to fact or otherwise made by or on behalf of the Agent
      or the Corporation and that the Purchaser’s decision (or the decision of
      others for whom the Purchaser is contracting hereunder) is based entirely
      upon publicly available information concerning the Corporation (any such
      information having been delivered to the Purchaser without independent
      investigation or verification by the
Agent);

            


    


    
      
         


      

      
        3

        
          

        

      

      
         


      

    

     

    
      	
              (g)

            	
              the
      Agent and its directors, officers, employees, agents and representatives
      assume no responsibility or liability of any nature whatsoever for the
      accuracy or adequacy of any such publicly available information or as to
      whether all information concerning the Corporation required to be
      disclosed by it has been generally
disclosed;

            


    

     

    
      	
              (h)

            	
              as
      at the Closing Date, the Units (and the underlying securities) have not
      been registered under the U.S. Securities Act of 1933,
      as amended (the “Securities Act”), with the result that the Purchased
      Units (and the underlying securities) are “restricted securities” within
      the meaning of Regulation S and Rule 144 promulgated under the Securities
      Act and, absent registration under the Securities Act, may not be offered
      or sold within the United States or to or for the account or benefit of a
      U.S. Person (as defined in Rule 902(o) of Regulation S promulgated under
      the Securities Act) except pursuant to an exemption from the registration
      requirements of the Securities Act such as that provided by Rule
      144;

            


    

     

    
      	
              (i)

            	
              the
      Purchaser (or others for whom the Purchaser is contracting hereunder) has
      been advised to consult its own legal advisors with respect to any
      applicable resale restrictions and the Purchaser (or others for whom the
      Purchaser is contracting hereunder) is solely responsible (and neither the
      Corporation nor the Agent is in any way responsible) for compliance with
      applicable resale restrictions;

            


    

     

    
      	
              (j)

            	
              no
      person has made any written or oral
  representations;

            


    

     

    
      	
               
      

            	
              (i)

            	
              that
      any person will resell or repurchase the
Units;

            


    

     

    
      	
               
      

            	
              (ii)

            	
              that
      the Units (or the underlying securities) will be freely tradeable by the
      Purchaser without any restrictions or hold
  periods;

            


    

     

    
      	
               
      

            	
              (iii)

            	
              that
      any person will refund the purchase price of the Purchased Units;
      or

            


    

     

    
      	
               
      

            	
              (iv)

            	
              as
      to the future price or value of the Purchased Units (or the underlying
      securities).

            


    

     

    
      	
              (k)

            	
              the
      Purchaser understands and agrees that, except as provided below in this
      paragraph (k), each certificate delivered to the Purchaser representing
      the Purchased Units shall bear a legend in substantially the following
      form (in addition to any legend required under applicable state securities
      laws):

            


    


    
      
         


      

      
        4

        
          

        

      

      
         


      

    


    “THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) AND MAY ONLY BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION (A)
TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 903 OR
904 OF REGULATION S UNDER THE 1933 ACT OR (C) PURSUANT TO AN AVAILABLE EXEMPTION
FROM SUCH REGISTRATION REQUIREMENTS, PROVIDED IN SUCH LATTER CASE THAT THE
HOLDER UPON REQUEST PRIOR TO SUCH SALE FURNISHES TO THE CORPORATION AN OPINION
OF COUNSEL OF RECOGNIZED STANDING TO THAT EFFECT REASONABLY SATISFACTORY TO THE
CORPORATION.  HEDGING TRANSACTIONS INVOLVING THE SECURITIES
REPRESENTED HEREBY MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933
ACT.”

     

    Certificates
evidencing the Purchased Units (and the underlying securities including any
shares of Common Stock issued on, or resulting from, the exercise of the
Warrants) shall not be required to contain the foregoing legend (i) following
any sale of such shares pursuant to Rule 144 if the Purchaser provides the
Corporation with a legal opinion reasonably acceptable to the Corporation to the
effect that the shares can be sold under Rule 144, (ii) if and for so long as
the Purchased Units (and the underlying securities including any shares of
Common Stock issued on, or resulting from, the exercise of the Warrants) are
eligible for sale under the last sentence of Rule 144(b)(1)(i) or (iii) if the
holder provides the Corporation with a legal opinion reasonably acceptable to
the Corporation to the effect that the legend is not required under applicable
requirements of the Securities Act.

     

    
      	
              (l)

            	
              the
      Purchaser’s investment in the Purchased Units involves a significant
      degree of risk, including a risk of total loss of the Purchaser’s
      investment, and the Purchaser has full knowledge of and understands all of
      the risk factors related to the Purchaser’s purchase of the Purchased
      Units;

            


    

     

    
      	
              (m)

            	
              the
      Purchaser has the knowledge and experience in financial and business
      matters and is capable of assessing the proposed investment in the Units
      as a result of its financial and investment experience and business acumen
      or as a result of advice received from a registered person and is capable
      of evaluating the merits and risks of its investment in the Units and is
      able to bear the economic risk of a loss of its entire investment in the
      Purchased Units.

            


    

     

    6.           Representations, Warranties
and Covenants of the Corporation

     

    The
Corporation represents, warrants and covenants to the Agent, the Purchaser (and
to any others on whose behalf the Purchaser is contracting hereunder) as of the
date hereof and as of the Closing Date, which representations, warranties and
covenants shall survive any investigation made by the Agent, the Purchaser or
such others for a period of two years after the Final Closing,
that:

     

    
      
         


      

      
        5

        
          

        

      

      
         


      

    

     

    
      	
              (a)

            	
              the
      Corporation is a validly existing corporation in good standing under the
      laws of the jurisdiction in which it is incorporated, and the Corporation
      has no subsidiaries;

            


    

     

    
      	
              (b)

            	
              the
      Corporation is duly qualified and authorized to do business in the
      jurisdiction(s) in which it carries on business or to own property where
      required under the laws of the jurisdiction(s) in which any such property
      is located;

            


    

     

    
      	
              (c)

            	
              the
      Corporation is current with all material filings required to be made under
      the laws of any jurisdiction in which it carries on any material business,
      and the Corporation has all necessary licenses, leases, permits,
      authorizations and other approvals necessary to permit it to conduct its
      business as currently conducted, except where the failure to have any such
      license, lease, permit, authorization or approval would not have a
      material adverse effect on the Corporation and its
    business;

            


    

     

    
      	
              (d)

            	
              the
      audited financial statements of the Corporation as at and for the year
      ended December 31, 2008 and the interim financial statements of the
      Corporation as at and for the six-month period ended June 30, 2009 present
      fairly, in all material respects, the financial position of the
      Corporation as at the respective period-end dates, and the results of its
      operations and the changes in its financial position for the 12-month
      period ended December 31, 2008 in the case of the audited financial
      statements and six-month period ended June 30, 2009 in the case of the
      interim financial statements, all in accordance with generally accepted
      accounting principles,  and, since June 30, 2009, there has been
      no material adverse change in the business, affairs or financial or other
      condition of the Corporation, except as disclosed in the notes to the
      financial statements for the quarter then
ended;

            


    

     

    
      	
              (e)

            	
              the
      Corporation has all requisite power and authority to carry out its
      obligations under this Subscription
Agreement;

            


    

     

    
      	
              (f)

            	
              this
      Subscription Agreement has been duly authorized, executed and delivered by
      the Corporation and constitutes or on the Closing Date will constitute, a
      legal, valid and binding obligation of the Corporation enforceable in
      accordance with its terms except that: (i) the enforcement hereof may
      be limited by bankruptcy, insolvency, reorganization and other laws
      affecting the enforcement of creditors’ rights generally, (ii) rights
      of indemnity hereunder may be limited under applicable law, and
      (iii) equitable remedies, including without limitation specific
      performance and injunctive relief, may be granted only in the discretion
      of a court of competent
jurisdiction;

            


    

     

    
      	
              (g)

            	
              the
      shares of Common Stock included in the Units are or on the Closing Date
      will be duly and validly authorized and, when issued and delivered against
      payment therefor, will be duly and validly issued, fully paid and
      non-assessable shares in the capital stock of the
    Corporation;

            


    

     

    
      	
              (h)

            	
              the
      Corporation will reserve a sufficient number of shares of Common Stock out
      of its authorized capital stock as may be required to be issued on, or
      resulting from, the exercise of the Warrants and, when issued and
      delivered upon such exercise, such shares of Common Stock will be duly and
      validly issued as fully paid and non-assessable shares in the capital of
      the Corporation;

            


    

     

    
      
         


      

      
        6

        
          

        

      

      
         


      

    

     

    
      	
              (i)

            	
              the
      authorized capital of the Corporation consists of 150,000,000 shares of
      Common Stock and 5,000,000 shares of preferred stock, par value of $0.01
      per share.  Of the preferred stock, 200,000 shares have been
      designated as Series D Junior Participating Preferred Stock (underlying
      outstanding rights applicable to each presently and future outstanding
      share of Common Stock under a shareholder rights agreement adopted
      effective May 20, 2008 (the “Rights Plan”) and no other series or class of
      preferred stock is designated.  As of June 30, 2009 there were
      99,639,106 shares of Common Stock and no shares of preferred stock
      outstanding.  In addition, as of that date, the Corporation had
      an aggregate of 26,074,666 shares of Common Stock reserved for issuance
      upon exercise or conversion of the following outstanding securities: (i)
      options which have been granted under the Corporation’s  stock
      option plans and other agreements, to purchase an aggregate
      of  13,689,666 shares of Common Stock  and (ii)
      warrants issued to investors to purchase an aggregate of 10,000,000 shares
      of Common Stock and warrants issued to the Agent or its designees to
      purchase an aggregate of 2,385,000 shares of Common
  Stock;

            


    

     

    
      	
              (j)

            	
              the
      Corporation is not, and at the Closing Date will not be: (i) in
      breach or violation of any of the terms or provisions of, or in default
      under, this Agreement, any other Subscription Agreement for the purchase
      of Units, the Agency Agreement, any indenture, mortgage, deed of trust or
      loan agreement, (except as disclosed in the Corporation’s SEC filings),
      other agreement (written or oral) or instrument to which it is a party or
      by which it is bound or to which any of its property or assets is subject,
      which breach or violation or the consequences thereof would result in a
      material adverse change to it or its business; or (ii) in violation
      of the provisions of its articles, by-laws, resolutions or any statute or
      any other rule or regulation of any court or governmental agency or body
      having jurisdiction over it or any of its properties which violation or
      the consequences thereof would result in a material adverse change to it
      or its business;

            


    

     

    
      	
              (k)

            	
              the
      issue and sale of the Purchased Units (and the underlying securities
      including any shares of Common Stock issued on, or resulting from, the
      exercise of the Warrants) and the performance and consummation of the
      transactions contemplated herein will not conflict with or result in a
      breach or violation of any of the terms or provisions of, or constitute a
      default under, any indenture, mortgage, deed of trust, loan agreement or
      other agreement (written or oral) or instrument to which the Corporation
      is bound or to which any of the property or assets of the Corporation is
      subject, which breach or violation or the consequences thereof would
      result in a material adverse change to the Corporation or its business,
      nor will any such action conflict with or result in any violation of the
      provisions of the articles, by-laws or resolutions of the Corporation or
      any statute or any order, rule or regulation of any court or governmental
      agency or body having jurisdiction over the Corporation or any of its
      properties which violation or the consequences thereof would result in a
      material adverse change to the Corporation or its
  business;

            


    

     

    
      
         


      

      
        7

        
          

        

      

      
         


      

    


    
      	
              (l)

            	
              the
      Corporation has established on its books reserves which are adequate for
      the payment of all taxes not yet due and payable; there are no liens or
      other liabilities for taxes on the assets of the Corporation except for
      taxes not yet due; there are no audits of any of the tax returns of the
      Corporation which are known by the Corporation’s management to be pending
      and there are no claims which have been or may be asserted relating to any
      such tax returns which, if determined adversely, would result in the
      assertion by any government or agency of any deficiency having a material
      adverse effect on the properties, business or assets of the
      Corporation;

            


    

     

    
      	
              (m)

            	
              the
      Corporation has good and valid title to its properties, leaseholds and
      assets, including without limitation the properties, leaseholds and assets
      reflected in the balance sheet as of June 30, 2009 referred to in Section
      6(d) above, except properties, leaseholds and assets disposed of since
      such date at fair market value in the ordinary course of business, and has
      good title to all its leasehold estates, in each case subject to no
      mortgage, pledge, lien, lease, encumbrance, charge, rights of first
      refusal or options to purchase, whether or not relating to extensions of
      credit or the borrowing of money, other than as disclosed in such balance
      sheet except as incurred in the ordinary course of business since the date
      of such balance sheet, and except in any event where the failure to hold
      good title or the existence of a mortgage, pledge, lien, lease,
      encumbrance, charge, right of first refusal or option to purchase would
      not have a material adverse effect on the Corporation or its business;
      there exists no condition which interferes with the economic value or use
      of such properties and assets and all tangible assets are in good working
      condition and repair (subject to ordinary wear and tear) except where the
      existence of any such condition would not have a material adverse effect
      on the Corporation or its business;

            


    

     

    
      	
              (n)

            	
              the
      Corporation owns or has valid licenses for the use of, or has applied for
      registration of, all patents, trade marks, service marks, trade names, and
      copyrights necessary for the conduct of its business, except where the
      failure to so own or apply for registration would not have a material
      adverse effect on the Corporation or its business; to the best of the
      knowledge, information and belief of the Corporation, none of the past or
      present activities of the Corporation or the products, services or assets
      of the Corporation infringe or constitute an unauthorized use of any
      proprietary rights of others, and the Corporation has not received any
      notice of infringement of, or conflict with, asserted rights of others
      with respect to any patent, trade mark, service mark, trade name, or
      copyright that, individually or in the aggregate, if the subject of an
      unfavorable decision, ruling, or finding, would result in a material
      adverse change to the Corporation or its
  business;

            


    

     

    
      	
              (o)

            	
              the
      Corporation has taken reasonable measures to protect and preserve the
      confidentiality of all trade secrets and other non-patented proprietary
      information of the Corporation, including without limitation the
      procurement of proprietary invention assignments and non-disclosure and
      non-competition agreements from employees, consultants, subcontractors,
      customers and other persons who have access to such
      information;

            


    

     

    
      	
              (p)

            	
              the
      Corporation has filed all necessary federal, state and municipal property,
      income and franchise tax returns and has paid all taxes shown as due
      thereon or otherwise owed by it to any taxing authority except those
      contested in good faith and for which appropriate amounts have been
      reserved in accordance with generally accepted accounting principles;
      there is no tax deficiency which has been, or to the best of the
      knowledge, information and belief of the Corporation might be, asserted
      against the Corporation which would materially affect the business or
      operations of the Corporation; the Corporation has paid all applicable
      federal and state payroll and withholding
taxes;

            


    

     

    
      
         


      

      
        8

        
          

        

      

      
         


      

    

     

    
      	
              (q)

            	
              there
      is no collective bargaining or other union agreement to which the
      Corporation is a party or by which it is bound, or which is currently
      being negotiated; except for a defined contribution plan under Section
      401(k) of the US Internal Revenue Code, the Corporation does not sponsor,
      maintain or contribute to any pension, retirement, profit sharing,
      incentive compensation, bonus or other employee benefit plan, including
      without limitation any employee benefit plan covered by Title 4 of the
      Employee Retirement
      Income Security Act of 1974 (“ERISA”) or any “multi-employer plan”
      as defined in Section 4001(a)(3) of ERISA, or any other employee benefit
      plan; to the best of the knowledge, information and belief of the
      Corporation, (i) no employee of the Corporation is a party to or
      bound by any agreement, contract or commitment, or subject to any
      restrictions, particularly but without limitation in connection with any
      previous employment of any such person, which would result in a material
      adverse change to the Corporation or its business, and (ii) no senior
      officer has any present intention of terminating his employment with the
      Corporation, and the Corporation has no present intention of terminating
      any such employment; and

            


    

     

    
      	
              (r)

            	
              there
      is no adverse claim, action, proceeding or investigation pending or, to
      the knowledge, information and belief of the Corporation, threatened,
      which questions the validity of the issue or sale of the Units (or the
      underlying securities, including the shares of Common Stock issued on, or
      resulting from, the exercise of the Warrants) contemplated hereunder or
      the validity of any action taken or to be taken by the Corporation in
      connection with this Subscription Agreement or which would result in any
      material adverse change in the financial condition, results of operations,
      business or prospects of the
Corporation.

            


    

     

    7.           Representations, Warranties
and Covenants of the Purchaser

     

    The
Purchaser represents, warrants and covenants to the Agent and the Corporation
(which representations, warranties and covenants shall survive the Closing and
continue in full and force and effect) that:

     

    
      	
              (a)

            	
              in
      the case of the subscription by the Purchaser for Units as principal for
      its own account and not for the benefit of any other person, the Purchaser
      is purchasing the Purchased Units as principal for its own account, and
      not for the benefit of any other person or company, and this Subscription
      Agreement has been authorized, executed and delivered by, and constitutes
      a legal, valid and binding agreement of the
  undersigned;

            


    

     

    
      	
              (b)

            	
              in
      the case of the subscription by the Purchaser for Units as agent for a
      disclosed principal, each beneficial purchaser of the Purchased Units for
      whom the Purchaser is acting is purchasing as principal for its own
      account and not for the benefit of any other person and the Purchaser is
      an agent with due and proper authority to execute this Subscription
      Agreement and all other documentation in connection with the purchase of
      the Purchased Units on behalf of the beneficial purchaser and this
      Subscription Agreement has been duly authorized, executed and delivered by
      or on behalf of, and constitutes a legal, valid and binding agreement of,
      the disclosed principal;

            


    

     

    
      
         


      

      
        9

        
          

        

      

      
         


      

    

     

    
      	
              (c)

            	
              in
      the case of the subscription by the Purchaser of Units as trustee or as
      agent for a principal which is undisclosed or identified by account number
      only, this Subscription Agreement has been duly authorized, executed and
      delivered by, and constitutes a legal, valid and binding agreement of, the
      undersigned acting in such
capacity;

            


    

     

    
      	
              (d)

            	
              if
      the Purchaser is a corporation, the Purchaser is a valid and subsisting
      corporation, has the necessary corporate capacity and authority to execute
      and deliver this Subscription Agreement and to observe and perform its
      covenants and obligations hereunder and has taken all necessary corporate
      action in respect thereof or, if the Purchaser is a partnership, syndicate
      or other form of unincorporated organization, the Purchaser has the
      necessary legal capacity and authority to execute and deliver this
      Subscription Agreement and to observe and perform its covenants and
      obligations hereunder and has obtained all necessary approval in respect
      thereof and, in either case, upon execution by the Corporation, this
      Subscription Agreement constitutes a legal, valid and binding contract of
      the Purchaser enforceable against the Purchaser in accordance with its
      respective terms;

            


    

     

    
      	
              (e)

            	
              if
      the Purchaser is an individual, the Purchaser has attained the age of
      majority and is legally competent to execute this Subscription Agreement
      and to take all actions required pursuant
  hereto;

            


    

     

    
      	
              (f)

            	
              if
      the Purchaser is a US Person within the meaning of Rule 902(o) of
      Regulation S promulgated under the Securities Act of 1933 (“US Person”),
      the Purchaser (1) has read carefully the definition of “Accredited
      Investor” contained in Schedule 1 attached hereto and (2) meets the
      standards of an “Accredited Investor” set forth under Rule 501(a) of
      Regulation D under the Act and has such knowledge and experience in
      financial and business matters that the Investor is capable of evaluating
      the merits and risks of an investment in the Corporation’s securities. The
      Purchaser will promptly notify the Corporation in the event that prior to
      the issuance of any securities to the Purchaser the foregoing
      representation ceases to be
accurate.

            


    

     

    
      	
              (g)

            	
              if
      the Purchaser is not a US Person, the Purchaser makes the representations
      and warranties set forth on Schedule 2
hereto.

            


    

     

    
      	
              (h)

            	
              if
      required by applicable securities legislation, policy or order of a
      securities regulatory authority or other regulatory authority, the
      Purchaser will execute, deliver, file and otherwise assist the Corporation
      in filing such reports and other documents with respect to the issue of
      the Purchased Units (or the underlying securities) as may be reasonably
      required;

            


    

     

    
      
         


      

      
        10

        
          

        

      

      
         


      

    


    
      	
              (i)

            	
              the
      Purchaser has had access to the Corporation’s public filings with the SEC
      (which are accessible via the SEC’s EDGAR Archives located on the internet
      at www.sec.gov)
      and has had an opportunity to conduct due diligence and to ask and have
      answered questions of the Corporation’s management. The Purchaser
      acknowledges the existence of the Rights Plan, as described in detail in
      the Corporation’s Current Report on Form 8-K filed with the SEC on May 27,
      2008, which includes a 15% trigger level for determining a shareholder’s
      status as an “Acquiring Person,” and the potential for significant
      dilution to the Purchaser’s equity stake in the Corporation should the
      Purchaser be deemed an “Acquiring
Person”;

            


    

     

    
      	
              (j)

            	
              the
      Purchaser is capable of assessing the proposed investment as a result of
      the Purchaser’s financial or investment experience or as a result of
      advice received from a registered person other than the Corporation or an
      affiliate thereof, and is able to bear the economic loss of its
      investment.  The Purchaser recognizes that its purchase of
      Purchased Units involves a high degree of risk in that: (i) the
      Corporation has incurred losses since inception; at June 30, 2009, the
      Corporation had an accumulated deficit of approximately $59,316,000
      (unaudited); and the Corporation may require substantial funds in addition
      to the proceeds of this Offering to continue its plan of operations;
      (ii) an investment in the Corporation is highly speculative and only
      investors who can afford the loss of their entire investment should
      consider investing in the Corporation and the Purchased Units (and the
      underlying securities); (iii) the Purchaser may not be able to
      liquidate the Purchaser’s investment; and (iv) transferability of the
      securities comprising the Purchased Units (and the underlying securities
      including any shares of Common Stock issued on, or resulting from, the
      exercise of the Warrants) is extremely limited.  The Purchaser
      has read the Risk Factors section of the Corporation’s Annual Report on
      Form 10-KSB for the year ended December 31,
  2008;

            


    

     

    
      	
              (k)

            	
              the
      Purchaser is aware of the restrictions with respect to trading in the
      Units (and the underlying securities including any shares of Common Stock
      issued on, or resulting from, the exercise of the Warrants) imposed by
      applicable securities laws and confirms that no representation has been
      made respecting the restrictions with respect to trading the Units and the
      Purchaser further covenants that it will not resell the Units (or the
      underlying securities) except in accordance with provisions of applicable
      securities laws;

            


    

     

    
      	
              (l)

            	
              the
      address of the Purchaser (or others for whom the Purchaser is contracting
      hereunder) furnished by the Purchaser on the Purchaser’s signature page of
      this Subscription Agreement is such person’s principal residence if such
      person is an individual or its principal business address if it is a
      corporation or other entity; and

            


    

     

    
      	
              (m)

            	
              the
      Purchaser (or others for whom the Purchaser is contracting hereunder)
      agrees that it will not disclose the terms of the Offering or any
      information it may have acquired from the Corporation in the course of
      executing this Subscription Agreement which the Corporation has identified
      as material non-public information, except to the extent (i) that
      such terms or other information becomes generally available to the public
      other than by disclosure in violation of this Subscription Agreement,
      (ii) that such information was properly within the Purchaser’s
      possession prior to being furnished by the Corporation, (iii) that
      such information becomes available to the Purchaser on a non-confidential
      basis, such as through disclosure by third parties who have the right to
      disclose the information, and (iv) that disclosure of such
      information is compelled by judicial process, provided that in the event
      of compulsion by judicial process the Purchaser will inform the
      Corporation promptly upon its receipt of notice of judicial process
      compelling such disclosure.

            


    

     

    
      
         


      

      
        11

        
          

        

      

      
         


      

    

     

    8.           Reliance Upon
Representations, Warranties and Covenants

     

    The
Purchaser acknowledges that the representations, warranties and covenants
contained in this Subscription Agreement are made with the intent that they may
be relied upon by the Agent and by the Corporation to, among other things,
determine the Purchaser’s eligibility or (if applicable) the eligibility of
others on whose behalf it is contracting hereunder to subscribe for the
Purchased Units.  The Purchaser further agrees that by accepting the
Purchased Units (and the underlying securities), the Purchaser shall be
representing and warranting that the foregoing representations and warranties
are true as at the Closing Time with the same force and effect as if they had
been made by the Purchaser at the Closing Time and that they shall survive the
purchase by the Purchaser of the Purchased Units and shall continue in full
force and effect notwithstanding any subsequent disposition by it of any
Purchased Units (or underlying securities).

     

    9.           Agent’s Commission, Fees and
Expenses

     

    The
Purchaser understands that on the Closing Date, the Agent will receive from the
Corporation a commission equal to 7% of the gross proceeds raised by the Agent
(payable in cash or in Units, or a combination thereof (at the issue price
thereof), the allocation of which to be designated by the Agent, in its sole
discretion, at the Closing Date) and broker warrants (the “Broker Warrants”) to
purchase, at any time up and until 5:00 p.m. (Eastern Standard Time) on
September 30, 2013 at an exercise price of $0.20 (US) per share (subject to
adjustment as provided in the Broker Warrants Certificates), that number of
shares of Common Stock equal to 7% of the number of Purchased Units issued in
respect of proceeds raised by the Agent, as more particularly described and
subject to the exclusions contained in the Agency Agreement. No other fee or
commission is payable by the Corporation in connection with the sale of the
Purchased Units.  However, the Corporation will also pay on the
Closing Date reasonable legal fees and expenses of the Agent’s counsel as
stipulated in the Agency Agreement.  The Purchaser understands and
acknowledges that a director of the Corporation also serves as a director and
officer of the Agent.

     

    10.         Costs

     

    The
Purchaser acknowledges and agrees that all costs and expenses incurred by the
Purchaser (including any fees and disbursements of any counsel retained by the
Purchaser) relating to the purchase of the Purchased Units shall be borne by the
Purchaser.

     

    11.         Appointment of
Agent

     

    The
Purchaser, on its own behalf and (if applicable) on behalf of others for whom
the Purchaser is contracting hereunder, hereby:

     

    
      
         


      

      
        12

        
          

        

      

      
         


      

    


    


     

    
      	
              (a)

            	
              irrevocably
      authorizes the Agent to negotiate and settle the form of any agreement to
      be entered into in connection with this Subscription Agreement and to
      waive on its own behalf and on behalf of the purchasers of Units, in whole
      or in part, or extend the time for compliance with, any of the closing
      conditions in such manner and on such terms and conditions as the Agent
      may determine, acting reasonably, without in any way affecting materially
      the Purchaser’s obligations or the obligations of such others hereunder;
      and

            


    

     

    
      	
              (b)

            	
              acknowledges
      and agrees that the Agent and the Corporation may vary, amend, alter or
      waive, in whole or in part, one or more of the conditions set forth in the
      Agency Agreement in such manner and on such terms and conditions as they
      may determine, acting reasonably, without in any way affecting materially
      the Purchaser’s obligations or the obligations of such others
      hereunder.

            


    

     

    12.         Governing
Law

     

    This
Subscription Agreement shall be governed by the laws of the State of New York
without reference to its rules as to conflicts of laws.

     

    13.         Third Party
Beneficiaries

     

    Except
for the limitation of liability provisions in Section 4 above, nothing herein,
express or implied, is intended to nor shall it, confer in any other Person any
legal or equitable right, benefit or remedy of any nature whatsoever under or by
reason of this Subscription Agreement.

     

    14.         Survival

     

    This
Subscription Agreement, including without limitation the representations,
warranties and covenants contained herein, shall survive and continue in full
force and effect and be binding upon the Purchaser for a period of six months
following the completion of the Offering by the Corporation, notwithstanding the
completion of the subscription for the Purchased Units by the Purchaser pursuant
hereto, and any subsequent disposition by the Purchaser of any Purchased
Units.

     

    15.         Assignment

     

    This
Subscription Agreement is not transferable or assignable by the parties
hereto.

     

    16.         Counterparts

     

    This
Subscription Agreement may be executed in counterparts, each of which shall be
deemed to be an original and all of which shall constitute one and the same
document.  The Corporation and the Agent shall be entitled to rely
upon delivery by facsimile of an executed copy of this Subscription Agreement
and acceptance by the Corporation of such facsimile copies will be legally
effective to create a valid and binding agreement between the Purchaser and the
Corporation in accordance with the terms hereof.


    
      
         


      

      
        13

        
          

        

      

      
         


      

    


    


     

    17.         Subscription
Particulars

     

    The
aggregate number of Units subscribed for is                               
for             an
            aggregate
subscription price of ___________.

     

    The
Purchased Units (and underlying securities) are to be registered in the name
of:

     

    
      
        	 
      
	
                (if
      space is insufficient, attach a
list)

              


      

    

     

    
      The
certificates representing the Purchased Units (and/or underlying securities) are
to be delivered to:

       

      
        
          	
                   

                


        

      

      


      at its
office at:

       

      
        
          	
                   

                
	 
      
	 
      


        

      

      


      Contact
Name, Number and E-mail:

       

      
        
          	
                   
      

                


        

      

      


      If the
Purchaser is signing as agent for a principal and not as agent for a fully
managed account, the name and address of the beneficial purchaser
is:

       

    

    
      
        	 
      
	 
      
	 
      
	
                (if
      space is insufficient, attach a
list)

              


      

    

    


    DATED
at                                       
this                      
day of                                ,
2009.

     

    
      
        
          	 
      
	
                  Name
      of Purchaser (please type or print)

                
	 	 
	
                  By:

                	 
      
	 
      	
                  (Signature
      of Authorized Representative)

                
	 
      	 
      
	 
      	
                  (Name
      of Person Signing)

                
	 
      	 
      
	 
      	
                  Office
      or Title

                
	 
      	 
      
	 
      	 
      
	
                  Address
      of Purchaser

                	 
      


        

      

    

     

    
      
         


      

      
        14

        
          

        

      

      
         


      

    


    ACCEPTANCE

     

    This
Subscription Agreement is hereby accepted and agreed to by SyntheMed,
Inc.

     

    DATED at Iselin, New Jersey,
the                 
day of                                    
2009.

     

    
      
        
          	
                  SYNTHEMED,
      INC.

                
	 
      	 
      
	
                  By:

                	 
      
	 
      	
                  Authorized
      Signing Officer

                


        

      

    

     

    
      
         


      

      
         


        
          

        

      

      
         


      

    


    Schedule
1

    ACCREDITED
INVESTOR

     

    An
“accredited investor” is defined as:

     

    
      	
              1.

            	
              A
      bank as defined in Section 3(a)(2) of the Securities Act, or a savings and
      loan association or other institution as defined in Section 3(a)(5)(A) of
      the Securities Act, whether acting in its individual or fiduciary
      capacity; a broker or dealer registered pursuant to Section 15 of the
      Securities Exchange Act of 1934; an insurance company as defined in
      Section 2(13) of the Securities Act; an investment company registered
      under the Investment Company Act of 1940 or a business development company
      as defined in Section 2(a)(48) of that Act; a Small Business Investment
      Company licensed by the United States Small Business Administration under
      Section 301(c) or (d) of the Small Business Investment Act of 1958; a plan
      established and maintained by a state, its political subdivisions, or any
      agency or instrumentality of a state or its political subdivisions, for
      the benefit of its employees, if such plan has total assets in excess of
      $5,000,000; an employee benefit plan within the meaning of the Employee
      Retirement Income Security Act of 1974 (“ERISA”), if the investment
      decision is made by a plan fiduciary, as defined in Section 3(21) of
      ERISA, which is either a bank, savings and loan association, insurance
      company, or registered investment advisor, or if the employee benefit plan
      has total assets in excess of $5,000,000 or, is a self-directed plan, with
      the investment decisions made solely by persons that are accredited
      investors;

            


    

     

    
      	
              2.

            	
              A
      private business development company as defined in Section 202(a)(22) of
      the Investment Advisers Act of
1940;

            


    

     

    
      	
              3.

            	
              An
      organization described in Section 501(c)(3) of the Internal Revenue Code,
      corporation, Massachusetts or similar business trust, or partnership, not
      formed for the specific purpose of acquiring the securities, with total
      assets in excess of $5,000,000;

            


    

     

    
      	
              4.

            	
              A
      director or executive officer of the
  Corporation;

            


    

     

    
      	
              5.

            	
              A
      natural person whose individual net worth, or joint net worth with that
      person’s spouse, at the time of such person’s investment exceeds
      $1,000,000;

            


    

     

    
      	
              6.

            	
              A
      natural person who had an individual income in excess of $200,000 in each
      of the two most recent years or joint income with that person’s spouse in
      excess of $300,000 in each of those years and which has a reasonable
      expectation of reaching the same income level in the current
      year;

            


    

     

    
      	
              7.

            	
              A
      trust with total assets in excess of $5,000,000, not formed for the
      specific purpose of acquiring the securities, whose purchase is directed
      by a sophisticated person as described in Rule 506(b)(2)(ii) of Regulation
      D; or

            


    

     

    
      	
              8.

            	
              An
      entity in which all of the equity owners are “accredited investors” under
      one or more of the foregoing
categories.

            


    

     

    
      
         


      

      
         


        
          

        

      

      
         


      

    


    Schedule
2

    NON
US PERSON REPRESENTATIONS

     

    Each
Purchaser who is not a US Person represents and warrants to the Corporation
that:

     

    
      	
              1.

            	
              Purchaser
      is neither a U.S. Person (as defined in Rule 902(o) of Regulation S
      promulgated under the Securities Act) nor is Purchaser committing to
      purchase securities for the account of a U.S. Person or for resale in the
      United States and the undersigned confirms that the securities have not
      been offered to the Purchaser in the United
  States.

            


    

     

    
      	
              2.

            	
              Purchaser:

            


    

     

    
      	
               
      

            	
              (a)

            	
              is
      not a “distributor” of securities as such term is defined in Regulation S
      nor a dealer in securities, and

            


    

     

    
      	
               
      

            	
              (b)

            	
              acknowledges
      that it has not engaged, and agrees that it will not engage during any
      period in which US securities laws prohibit such activity, in any hedging
      transactions with regard to the Corporation’s Common
  Stock.

            


    

     

    
      	
              3.

            	
              The
      investment commitment by the Purchaser does not contravene any of the
      applicable securities legislation in the jurisdiction in which the
      Purchaser is resident and does not
trigger:

            


    

     

    
      	
               
      

            	
              (a)

            	
              any
      obligation to prepare and file a prospectus or similar document, or any
      other report with respect to such purchase,
and

            


    

     

    
      	
               
      

            	
              (b)

            	
              any
      registration or other obligation on the part of Purchaser, the Corporation
      or the Agent.

            


    

     

    
      
         


      

      
         


        
          

        

      

      
         


      

    


    ANNEX
A

     

    Investor
Warrant No:

     

    THIS
WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), STATE SECURITIES LAWS IN THE UNITED STATES OR THE SECURITIES LAW OF ANY
OTHER COUNTRY AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR
OTHERWISE DISPOSED OF UNLESS (A) SUCH TRANSACTION OCCURS OUTSIDE THE UNITED
STATES IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 904 OF REGULATION S
UNDER THE ACT (OR SUCH SUCCESSOR RULE OR REGULATION THEN IN EFFECT), IF
APPLICABLE, AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS, (B) THIS
WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT ARE REGISTERED
UNDER THE ACT OR (C) SUCH TRANSACTION CONSTITUTES A TRANSACTION THAT OTHERWISE
DOES NOT REQUIRE REGISTRATION UNDER THE ACT OR ANY APPLICABLE STATE SECURITIES
LAWS, AND THE HOLDER PRIOR TO SUCH TRANSACTION HAS FURNISHED TO THE CORPORATION
AN OPINION OF COUNSEL OF RECOGNIZED STANDING TO THAT EFFECT REASONABLY
SATISFACTORY TO THE CORPORATION, SUBJECT IN EACH CASE TO ANY APPLICABLE UNITED
STATES FEDERAL OR STATE OR FOREIGN SECURITIES LAW RESTRICTIONS APPLICABLE TO THE
RESALE OF THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE OF THIS
WARRANT.

     

    THIS
WARRANT MAY NOT BE EXERCISED BY OR ON BEHALF OF A U.S. PERSON AND NO SECURITIES
MAY BE DELIVERED IN THE UNITED STATES UPON EXERCISE OF THIS WARRANT UNLESS THE
EXERCISE IS REGISTERED UNDER THE ACT OR AN EXEMPTION FROM SUCH REGISTRATION IS
AVAILABLE.  ANY PERSON EXERCISING THIS WARRANT WILL BE REQUIRED TO
PROVIDE (1) WRITTEN CERTIFICATION THAT IT IS NOT A U.S. PERSON WITHIN THE
MEANING OF REGULATION S OF THE ACT AND THAT THIS WARRANT IS NOT BEING EXERCISED
WITHIN THE UNITED STATES OR ON BEHALF OF, OR FOR THE ACCOUNT OR BENEFIT OF, A
U.S. PERSON OR A PERSON IN THE UNITED STATES, OR (2) A WRITTEN OPINION OF
COUNSEL OF RECOGNIZED STANDING TO THE EFFECT THAT THIS WARRANT AND THE SHARES
ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE ACT AND
UNDER ANY APPLICABLE U.S. STATE SECURITIES LAWS OR ARE EXEMPT FROM REGISTRATION
THEREUNDER.  HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT
BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT.

     

    WARRANT
TO PURCHASE COMMON STOCK

     

    ___________
Shares of Common Stock

     

    SYNTHEMED,
INC.

     

    THIS
CERTIFIES THAT, for good and valuable consideration, the receipt of which is
hereby acknowledged, [insert
name] (the “Warrantholder”) with an address at [insert address],is the
registered holder of this Warrant and is entitled to subscribe for and purchase
from SyntheMed, Inc., a
Delaware corporation (the “Corporation”), at any time after the date hereof and
before 5:00 p.m. (Eastern Standard Time) on, September 30, 2013 (the “Time of
Expiry”), up to _______________ fully paid and non-assessable shares of common
stock of the Corporation (“Shares”) par value $.001 (US) per Share of the
Corporation at an exercise price of $0.20 (US) per Share, subject to adjustment
as provided below (the “Exercise Price”).

     

    
      
         


      

      
         


        
          

        

      

      
         


      

    

     

    This
Warrant is subject to the provisions of a subscription agreement entered into
with the original warrantholder in connection with the offering referred to in
Section 1 below (the “Subscription Agreement”), and the following provisions,
terms and conditions:

     

    
      	
              1.

            	
              Designation

            


    

     

    This
warrant certificate is one of a series of warrant certificates (collectively,
the “Warrants”) issued pursuant to an offering by the Corporation of up to
10,000,000 units, each consisting of one Share and one Warrant to purchase one
Share for US$0.20.  As of the date of original issuance of this
Warrant, an aggregate of _______ units have been sold in the offering (including
the units of which this Warrant forms a part).

     

    
      	
              2.

            	
              Exercise
      of Warrant

            


    

     

    
      	
               
      

            	
              (a)

            	
              Election to
      Purchase.  This Warrant may be exercised by the
      Warrantholder prior to the Time of Expiry in whole or in part and in
      accordance with the provisions hereof by delivery of an Election to
      Purchase in a form substantially the same as that attached hereto as Annex
      “A”, properly completed and executed, together with this Warrant and
      payment of the Exercise Price for the number of Shares as to which this
      Warrant is being exercised as specified in the Election to Purchase to the
      Corporation at 200 Middlesex Essex Turnpike, Suite 210, Iselin, New Jersey
      08830, U.S.A., Attention:  Robert P. Hickey, or such other
      address as may be notified in writing by the Corporation. Payment shall be
      made in U.S. dollars by wire transfer or certified or bank cashier’s
      cheque payable to the order of the Corporation or by means of a cashless
      exercise pursuant to Section 2(b)
below.

            


    

     

    
      	
               
      

            	
              (b)

            	
              Cashless
      Exercise. If at any time after
      six months from the date of issuance of this Warrant (i) there is no
      effective registration statement registering the resale of the underlying
      Shares by the Holder and (ii) the underlying Shares are listed on a US
      stock exchange or quoted on the OTC Bulletin Board, this Warrant may also
      be exercised at such time by means of a “cashless exercise” in which the
      Holder shall be entitled to receive a certificate for the number of Shares
      equal to the quotient obtained by dividing [(A-B) (X)] by (A),
      where:

            


    

     

    
      	
               
      

            	
              (A)
      = the closing price per Share on the last trading day prior to the date
      of exercise;

            


    

     

    
      	
               
      

            	
              (B)
      = the Exercise Price of this Warrant, as adjusted;
  and

            


    

     

    
      	
               
      

            	
              (X)
      = the number of Shares for which this Warrant is being
      exercised.

            


    

     

    
      	
               
      

            	
              Upon
      any such exercise, and in satisfaction of payment of the aggregate
      Exercise Price, this Warrant shall be automatically cancelled with respect
      to that number of Shares as is equal in value to the aggregate Exercise
      Price, calculated as the quotient obtained by dividing [(B)(X)] by
      (A).

            


    

     

    
      
         


      

      
        - 2
-

        
          

        

      

      
         


      

    

     

    
      	
               
      

            	
              (c)

            	
              Exercise.  The
      Corporation shall, promptly following the date it receives a duly executed
      Election to Purchase, this Warrant and payment of the Exercise Price for
      the number of Shares specified in the Election to Purchase (the “Exercise
      Date”), issue or cause to be issued that number of Shares specified in the
      Election to Purchase as fully paid and non-assessable
      Shares.  Such duly executed Election to Purchase shall
      constitute the Warrantholder’s acknowledgement of and undertaking to
      comply to the reasonable satisfaction of the Corporation and its counsel,
      with all applicable laws, rules, regulations and policies of every stock
      exchange upon which the Shares of the Corporation may from time to time be
      listed or traded, and any other applicable governmental or regulatory
      authorities.

            


    

     

    
      	
               
      

            	
              (d)

            	
              Share
      Certificates.  As promptly as practicable after the
      Exercise Date (and in any event not later than 10 days after the Exercise
      Date), the Corporation shall send to the Warrantholder, registered in such
      name or names as the Warrantholder may direct or if no such direction has
      been given, in the name of the Warrantholder, a certificate or
      certificates for the number of Shares specified in the Election to
      Purchase. To the extent permitted by law, such exercise shall be deemed to
      have been effected as of the close of business on the Exercise Date, and
      at such time the rights of the Warrantholder with respect to the portion
      of the Warrant exercised shall cease, and the person or persons in whose
      name or names any certificate or certificates for Shares shall then be
      issuable upon such exercise shall be deemed to have become the holder or
      holders of record of the Shares represented
  thereby.

            


    

     

    
      	
               
      

            	
              (e)

            	
              Fractional
      Shares.  No fractional Shares shall be issued upon
      exercise of this Warrant and no payments or adjustment shall be made upon
      any exercise on account of any cash dividends on the Shares issued upon
      such exercise.  If any fractional interest in a Share would,
      except for the provisions of the first sentence of this subsection 2(e),
      be deliverable upon the exercise of this Warrant, the number of Shares to
      be issued to the Warrantholder upon the exercise of this Warrant shall be
      rounded to the nearest whole
number.

            


    

     

    
      	
               
      

            	
              (f)

            	
              Subscription for Less
      than Entitlement.  The Warrantholder may from time to
      time subscribe for and purchase a number of Shares less than the aggregate
      number which the holder is entitled to purchase pursuant to this
      Warrant.  In the event of a purchase of a number of Shares less
      than the aggregate number which may be purchased pursuant to this Warrant,
      the holder thereof shall be entitled to receive, without charge, a new
      Warrant certificate in respect of the balance of the Shares subject to
      this Warrant which were not purchased by the
  Warrantholder.

            


    

     

    
      	
               
      

            	
              (g)

            	
              Corporate
      Changes.  If the Corporation shall be a party to any
      reorganization, merger, dissolution or sale of all or substantially all of
      its assets (the “Event”), (other than a reorganization or merger in which
      the Corporation is the surviving entity) then the securities purchasable
      hereunder shall be the securities (the “Event Securities”) which the
      Warrantholder would have received or been entitled to receive in such
      Event if such Warrantholder had fully exercised this Warrant prior to the
      record date (or if there was no record date, then prior to the effective
      date) of such Event, and the Exercise Price shall be adjusted to be the
      amount determined by multiplying the Exercise Price in effect immediately
      prior to the Event by the number of Shares as to which this Warrant was
      unexercised immediately prior to the Event, and dividing the product
      thereof by the number of Event Securities; provided however, that the
      Event shall not be carried into effect unless all necessary steps have
      been taken to ensure that any surviving entity is subject to the terms of
      this Warrant as adjusted.

            


    

     

    
      
         


      

      
        - 3
-

        
          

        

      

      
         


      

    

     

    Notwithstanding
anything to the contrary contained in the immediately preceding paragraph, in
the event of a transaction contemplated by such paragraph in which the surviving
or purchasing corporation demands that all outstanding Warrants be extinguished
prior to the closing date of the contemplated transaction, the Corporation shall
give prior notice (the “Merger Notice”) thereof to the Warrantholders advising
them of such transaction. The Warrantholders shall have 10 days after the date
of the Merger Notice to elect to (i) exercise the Warrants in the manner
provided herein, or (ii) receive from the surviving or purchasing corporation
the same consideration receivable by a holder of the number of Shares for which
this Warrant might have been exercised immediately prior to such consolidation,
merger, sale, or purchase reduced by such amount of the consideration as has a
market value equal to the Exercise Price, as determined by the board of
directors of the Corporation in accordance with the terms of the Warrants. If
any Warrantholder fails to timely notify the Corporation of its election, the
Warrantholder shall be deemed for all purposes to have elected the option set
forth in (ii) above. Any amounts receivable by a Warrantholder who has elected
the option set forth in (ii) above shall be payable at the same time as amounts
payable to stockholders in connection with any such transaction.

     

    
      	
               
      

            	
              (h)

            	
              Subdivision or
      Consolidation of Shares

            


    

     

    
      	
               
      

            	
              (i)

            	
              In
      the event the Corporation shall subdivide its outstanding Shares into a
      greater number of Shares, the Exercise Price in effect immediately prior
      to such subdivision shall be proportionately reduced, and conversely, in
      the event the outstanding Shares of the Corporation shall be consolidated
      into a smaller number of Shares, the Exercise Price in effect immediately
      prior to such consolidation shall be proportionately
      increased.

            


    

     

    
      	
               
      

            	
              (ii)

            	
              Upon
      each adjustment of the Exercise Price as provided herein, the
      Warrantholder shall thereafter be entitled to acquire, at the Exercise
      Price resulting from such adjustment, the number of Shares (calculated to
      the nearest tenth of a Share) obtained by multiplying the Exercise Price
      in effect immediately prior to such adjustment by the number of Shares
      which may be acquired hereunder immediately prior to such adjustment and
      dividing the product thereof by the Exercise Price resulting from such
      adjustment.

            


    

     

    
      	
               
      

            	
              (i)

            	
              Change or
      Reclassification of Shares.  In the event the Corporation
      shall change or reclassify its outstanding Shares into a different class
      of securities, this Warrant shall be adjusted as follows so as to apply to
      the successor class of securities:

            


    

     

    
      	
               
      

            	
              (i)

            	
              the
      number and kind of the successor class of securities which the
      Warrantholder shall be entitled to acquire shall be the aggregate number
      and kind of securities which, if this Warrant had been exercised
      immediately prior to such change or reclassification, the Warrantholder
      would have been entitled to receive by reason of such change or
      reclassification; and

            


    

     

    
      
         


      

      
        - 4
-

        
          

        

      

      
         


      

    

     

    
      	
               
      

            	
              (ii)

            	
              the
      Exercise Price shall be determined by multiplying the Exercise Price in
      effect immediately prior to the change or reclassification by the number
      of Shares as to which this Warrant was unexercised immediately prior to
      the change or reclassification, and dividing the product thereof by the
      number of the successor class of securities determined in paragraph
      2(i)(i) hereof.

            


    

     

    
      	
               
      

            	
              (j)

            	
              Distribution to
      Shareholders.  If and whenever at any time prior to the
      Time of Expiry the Corporation shall fix a record date or if a date is
      otherwise established (any such date being hereinafter referred to in this
      subsection 2(j) as the “record date”) for the issuance of rights, options
      or warrants to all or substantially all the holders of the outstanding
      Shares of the Corporation entitling them, for a period expiring not more
      than 45 days after such record date, to subscribe for or purchase Shares
      of the Corporation or securities convertible into or exchangeable for
      Shares at a price per share or, as the case may be, having a conversion or
      exchange price per share less than 95% of the Fair Market Value (as
      hereinafter defined) on such record date, the Exercise Price shall be
      adjusted immediately after such record date so that it shall equal the
      price determined by multiplying the Exercise Price in effect on such
      record date by a fraction, of which the numerator shall be the total
      number of Shares outstanding on such record date plus a number equal to
      the number arrived at by dividing the aggregate price of the total number
      of additional Shares offered for subscription or purchase or, as the case
      may be, the aggregate conversion or exchange price of the convertible or
      exchangeable securities so offered by the Fair Market Value, and of which
      the denominator shall be the total number of Shares outstanding on such
      record date plus the total number of additional Shares so offered (or into
      which the convertible or exchangeable securities so offered are
      convertible or exchangeable); Shares owned by or held for the account of
      the Corporation or any subsidiary of the Corporation shall be deemed not
      to be outstanding for the purpose of any such computation; such adjustment
      shall be made successively whenever such a record date is fixed; to the
      extent that any rights or warrants are not so issued or any such rights or
      warrants are not exercised prior to the expiration thereof, the Exercise
      Price shall then be readjusted to the Exercise Price which would then be
      in effect if such record date had not been fixed or to the Exercise Price
      which would then be in effect based upon the number of Shares or
      conversion or exchange rights contained in convertible or exchangeable
      securities actually issued upon the exercise of such rights or warrants,
      as the case may be.

            


    

     

    
      	
               
      

            	
              (k)

            	
              Additional
      Subscriptions.  If at any time the Corporation grants to
      its shareholders the right to subscribe for and purchase pro rata
      additional securities of the Corporation (other than securities described
      in subsection (2)(j) hereof) or of any other corporation or entity, there
      shall be no adjustments made to the number of Shares or other securities
      subject to this Warrant or to the Exercise Price in consequence thereof
      and this Warrant shall remain
unaffected.

            


    

     

    
      	
               
      

            	
              (l)

            	
              Carry Over of
      Adjustments.  No adjustment of the Exercise Price shall
      be made if the amount of such adjustment shall be less than 1% of the
      Exercise Price in effect immediately prior to the event giving rise to the
      adjustment, provided however, that in such case any adjustment that would
      otherwise be required then to be made shall be carried forward and shall
      be made at the time of and together with the next subsequent adjustment
      which, together with any adjustment so carried forward, shall amount to at
      least 1% of the Exercise Price in effect prior to such
      adjustment.

            


    

     

    
      
         


      

      
        - 5
-

        
          

        

      

      
         


      

    

     

    
      	
               
      

            	
              (m)

            	
              Notice of
      Adjustment.  Upon any adjustment of the number of Shares
      and upon any adjustment of the Exercise Price, then and in each such case
      the Corporation shall give written notice thereof to the Warrantholder,
      which notice shall state the Exercise Price and the number of Shares or
      other securities into which each Warrant is exercisable resulting from
      such adjustment, and shall set forth in reasonable detail the method of
      calculation and the facts upon which such calculation is
      based.  Upon the request of a Warrantholder there shall be
      transmitted promptly to all Warrantholders a statement prepared by the
      firm of independent certified public accountants retained to audit the
      financial statements of the Corporation to the effect that such firm
      concurs in the Corporation’s calculation of the
  change.

            


    

     

    
      	
               
      

            	
              (n)

            	
              Other
      Notices.  If at any
time:

            


    

     

    
      	
               
      

            	
              (i)

            	
              the
      Corporation shall declare any dividend upon its
  Shares;

            


    

     

    
      	
               
      

            	
              (ii)

            	
              the
      Corporation shall offer for subscription pro rata to the holders of its
      Shares any additional shares of any class or other
  rights;

            


    

     

    
      	
               
      

            	
              (iii)

            	
              there
      shall be any capital reorganization or reclassification of the capital
      stock of the Corporation, or consolidation, amalgamation or merger of the
      Corporation with, or sale of all or substantially all of its assets to,
      another corporation; or

            


    

     

    
      	
               
      

            	
              (iv)

            	
              there
      shall be a voluntary or involuntary dissolution, liquidation or winding-up
      of the Corporation,

            


    

     

    then, in
any one or more of such cases, the Corporation shall give to the Warrantholder
(A) at least 20 days’ prior written notice of the date on which a record shall
be taken for such dividend, distribution or subscription rights or for
determining rights to vote in respect of any such reorganization,
reclassification, consolidation, merger, amalgamation, sale, dissolution,
liquidation or winding-up and (B) in the case of any such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or
winding-up, at least 20 days’ prior written notice of the date when the same
shall take place.  Such notice in accordance with the foregoing clause
shall also specify (1) in the case of any such dividend, distribution or
subscription rights, the date on which the holders of Shares shall be entitled
thereto, and (2) in the case of any transaction described in the foregoing
clauses (iii) and (iv), the date on which the holders of Shares are to be
entitled to exchange their Shares for securities or other property deliverable
upon such reorganization, reclassification, consolidation, merger, amalgamation,
sale, dissolution, liquidation or winding-up, as the case may be.

     

    
      	
               
      

            	
              (o)

            	
              Shares to be
      Reserved.  The Corporation will at all times keep
      available and reserve out of its authorized Shares, solely for the purpose
      of issue upon the exercise of this Warrant, such number of Shares as shall
      then be issuable upon the exercise of this Warrant.  The
      Corporation covenants and agrees that all Shares which shall be so
      issuable will, upon issuance, be duly authorized and issued, fully paid
      and non-assessable.  The Corporation will take all such action
      as may be necessary to assure that all such Shares may be so issued
      without violation of any applicable requirements of any stock exchange
      upon which the Shares of the Corporation may be listed or in respect of
      which the Shares are qualified for unlisted trading
      privileges.  The Corporation will take all such action as is
      within its power to assure that all such Shares may be so issued without
      violation of any applicable law.

            


    

     

    
      
         


      

      
        - 6
-

        
          

        

      

      
         


      

    

     

    
      	
               
      

            	
              (p)

            	
              Issue
      Tax.  The issuance of certificates for Shares upon the
      exercise of this Warrant shall be made without charge to the Warrantholder
      for any issuance tax in respect thereto, provided that the Corporation
      shall not be required to pay any tax which may be payable in respect of
      any transfer involved in the issuance and delivery of any certificate in a
      name other than that of the
Warrantholder.

            


    

     

    
      	
               
      

            	
              (q)

            	
              Fair Market
      Value.  For the purposes of any computation hereunder,
      unless otherwise specified, the “Fair Market Value” at any date shall be:
      (i) if the Shares are listed on a stock exchange or quoted on a similar
      securities market, the weighted average sale price per share for the
      Shares for any 20 consecutive trading days (selected by the Corporation)
      commencing not more than 25 trading days before such date on the principal
      stock exchange or similar securities market upon which the Shares are
      listed or quoted, as the case may be; or (ii) if the computation is being
      made in connection with a public offering of Shares, the gross
      distribution price per Share under the offering; or (iii) in all other
      cases, the Fair Market Value shall be determined by the Board of Directors
      in good faith, which determination shall be conclusive.  The
      weighted average sale price shall be determined by dividing the aggregate
      sale price of all Shares sold on the said exchange or market during the
      said 20 consecutive trading days by the total number of Shares so
      sold.

            


    

     

    
      	
               
      

            	
              (r)

            	
              The
      Shares issued upon exercise of this Warrant shall be subject to a stop
      transfer order and the certificate or certificates evidencing such Shares
      shall bear the following legend:

            


    

     

    THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), STATE SECURITIES
LAWS IN THE UNITED STATES OR THE SECURITIES LAWS OF ANY OTHER COUNTRY, AND MAY
NOT BE SOLD, TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS
(A) SUCH TRANSACTION OCCURS OUTSIDE THE UNITED STATES IN A TRANSACTION MEETING
THE REQUIREMENTS OF RULE 904 OF REGULATION S UNDER THE ACT (OR SUCH SUCCESSOR
RULE OR REGULATION THEN IN EFFECT), IF APPLICABLE, AND IN COMPLIANCE WITH
APPLICABLE STATE SECURITIES LAWS, (B) THE SECURITIES REPRESENTED BY THIS
CERTIFICATE ARE REGISTERED UNDER THE ACT OR (C) SUCH TRANSACTION CONSTITUTES A
TRANSACTION THAT OTHERWISE DOES NOT REQUIRE REGISTRATION UNDER THE ACT OR ANY
APPLICABLE STATE SECURITIES LAWS, AND THE HOLDER PRIOR TO SUCH TRANSACTION HAS
FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OF RECOGNIZED STANDING TO
THAT EFFECT REASONABLY SATISFACTORY TO THE CORPORATION, SUBJECT IN EACH CASE TO
ANY APPLICABLE UNITED STATES FEDERAL, STATE OR FOREIGN SECURITIES LAW
RESTRICTIONS APPLICABLE TO THE RESALE OF THIS WARRANT AND THE SHARES ISSUABLE
UPON EXERCISE OF THIS WARRANT.

     

    
      
         


      

      
        - 7
-

        
          

        

      

      
         


      

    


    
      	
              3.

            	
              Transfer

            


    

     

    Subject
to compliance by the Warrantholder with any applicable resale restrictions, the
Corporation acknowledges and agrees that this Warrant may be assigned or
transferred by the Warrantholder at the Warrantholder’s option. It is the sole
responsibility of the Warrantholder to ensure that all such restrictions have
been observed.  Upon any permitted assignment or transfer, the
Warrantholder shall furnish the Corporation with such information including a
properly completed and executed form substantially the same as that attached
hereto as Annex “B”, regarding the transferee as the Corporation may reasonably
require to register this Warrant in the name of the transferee.  The
Corporation shall be obligated to refuse to register any proposed transfer of
this Warrant or underlying Shares unless made in accordance with the provisions
of Regulations S, pursuant to registration under the Act or pursuant to an
available exemption from registration.

     

    
      	
              4.

            	
              Replacement

            


    

     

    Upon
receipt of evidence satisfactory to the Corporation of the loss, theft,
destruction or mutilation of this Warrant and, if requested by the Corporation,
upon delivery of a bond of indemnity satisfactory to the Corporation (or, in the
case of mutilation, upon surrender of this Warrant), the Corporation will issue
to the Warrantholder a replacement Warrant (containing the same terms and
conditions as this Warrant).

     

    
      	
              5.

            	
              Expiry
      Date

            


    

     

    This
Warrant shall expire and all rights to purchase Shares hereunder shall cease and
become null and void at 5:00 p.m. (Eastern Standard Time) on September 30,
2013.

     

    
      	
              6.

            	
              Amendment

            


    

     

    Neither
this Warrant nor any term hereof may be changed, waived, discharged or
terminated except by an instrument in writing signed by the party against which
enforcement of the change, waiver, discharge or termination is
sought.

     

    
      	
              7.

            	
              Governing
      Law

            


    

     

    The laws
of the State of New York and applicable federal laws of the United States shall
govern this Warrant.

     

    
      	
              8.

            	
              Successors

            


    

     

    This
Warrant shall enure to the benefit of and shall be binding upon the
Warrantholder and the Corporation and their respective successors.

     

    [signature
page follows]


    
      
         


      

      
        - 8
-

        
          

        

      

      
         


      

    

     

     

    IN
WITNESS WHEREOF the Corporation has caused this Warrant to be signed by its duly
authorised officer and its corporate seal hereto affixed.

     

    DATED:  September          ,
2009.

     

    
      
        	
                SYNTHEMED,
      INC.

              
	 
      
	
                By:

              


      

    


    
      
         


      

      
        - 9
-

        
          

        

      

      
         


      

    


    Annex
“A” to Warrant

     

    Election
to Purchase

     

    The undersigned Warrantholder hereby
irrevocably elects to exercise the attached Warrant with respect to
_____________ of the Shares covered thereby, and tenders herewith the Warrant
and payment of the exercise price in full, together with all applicable transfer
taxes, if any. This election is being made in accordance with and subject to the
terms and conditions of the Warrant.

     

    Payment is being made in the form of
(check applicable
box):

     

    o           lawful
money of the United States by wire transfer to an account designated
by SyntheMed, Inc.or a certified or cashier’s cheque or bank
draft  payable to the order of SyntheMed, Inc. for the aggregate
exercise price; or

     

    o           the
cancellation of the Warrant with respect to that number of underlying Shares as
is equal in value to the aggregate exercise price, calculated in accordance with
Section 2(b)of the Warrant.

     

    The undersigned requests that such
Shares  be registered and a certificate or certificates
therefor  be issued and delivered as follows:

     

    Direction as to Registration
and Delivery

     

    
      
        
          
            	
                    Name
      of Registered Holder:

                  	
                      

                  
	 
      	 
      
	
                    Address
      of Registered Holder:

                  	
                      

                  
	 	 
	 
      	
                      

                  
	 
      	 
      
	
                    Delivery
      Address (if different from

                  	 
      
	
                    address
      of Registered Holder):

                  	
                      

                  
	 
      	 
      
	 
      	
                      

                  


          

        

      

    

     

    ______________________________________

    (Name of
Warrantholder)

     

    By: ______________________________________

    (Signature
of Warrantholder or, if not a natural person, signature of authorized
signatory)

    


    ______________________________________

    (Name and
Title of authorized signatory, if applicable)

    


    Date:___________________________________


    
      
         


      

      
         


        
          

        

      

      
         


      

    


    Annex
“B”

     

    
      	
              TO: 

            	
              SYNTHEMED,
      INC.

            


    

     

    FOR VALUE
RECEIVED, the undersigned hereby sells, transfers and assigns unto
____________________________________ the within warrant (herein called the
“Warrant”).  The undersigned hereby irrevocably instructs you to
transfer the Warrant on your books of registration and to issue in substitution
therefor a new warrant exercisable for the same number of shares or other
securities or property as the Warrant.

     

    DATED
the                                           day
of                                           ,           .

     

    Signature
of Transferor is

    hereby
guaranteed:

     

    Note:     The
signature to this Warrant transfer must correspond with the name as set forth on
the face of the Warrant in every particular without alteration or enlargement or
any change whatsoever, and must be guaranteed by a bank or other financial
institution acceptable to the Corporation.